CD (Suzhou) Biopharma Announces FDA Clearance for Phase I Clinical Trial of CD-001 ...Middle East

PR Newswire - News
CD (Suzhou) Biopharma Announces FDA Clearance for Phase I Clinical Trial of CD-001
SUZHOU, China, Sept. 20, 2024 /PRNewswire/ -- CD (Suzhou) Biopharma has received clearance from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application of CD-001, entering a Phase I first-in-human trial. CD-001, the company's leading clinical...

Hence then, the article about cd suzhou biopharma announces fda clearance for phase i clinical trial of cd 001 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( CD (Suzhou) Biopharma Announces FDA Clearance for Phase I Clinical Trial of CD-001 )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News